Litracen: Difference between revisions
CSV import |
CSV import |
||
| Line 60: | Line 60: | ||
[[Category:Antidepressants]] | [[Category:Antidepressants]] | ||
[[Category:Serotonin-norepinephrine reuptake inhibitors]] | [[Category:Serotonin-norepinephrine reuptake inhibitors]] | ||
<gallery> | |||
File:Litracen.png|Litracen | |||
</gallery> | |||
Latest revision as of 01:29, 20 February 2025
Overview of the medication Litracen
| Litracen | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Litracen is a pharmaceutical drug used primarily in the treatment of anxiety disorders and depression. It belongs to the class of medications known as antidepressants, specifically functioning as a serotonin-norepinephrine reuptake inhibitor (SNRI).
Mechanism of Action[edit]
Litracen works by inhibiting the reuptake of two key neurotransmitters in the brain: serotonin and norepinephrine. By preventing the reabsorption of these neurotransmitters, Litracen increases their availability in the synaptic cleft, thereby enhancing neurotransmission and improving mood and anxiety symptoms.
Indications[edit]
Litracen is indicated for the treatment of several conditions, including:
Dosage and Administration[edit]
Litracen is typically administered orally, with the dosage varying based on the specific condition being treated and the patient's response to the medication. It is important for patients to follow their healthcare provider's instructions regarding dosage and administration.
Side Effects[edit]
Common side effects of Litracen may include:
Serious side effects, though rare, can occur and may include:
Contraindications[edit]
Litracen is contraindicated in patients with:
- Known hypersensitivity to Litracen or any of its components
- Concurrent use of monoamine oxidase inhibitors (MAOIs)
Interactions[edit]
Litracen can interact with several other medications, including:
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
- Tricyclic antidepressants (TCAs)
Pharmacokinetics[edit]
Litracen is well absorbed from the gastrointestinal tract and undergoes extensive hepatic metabolism. It has a half-life of approximately 12 hours, allowing for once or twice daily dosing.
History[edit]
Litracen was first developed in the late 20th century and received approval for medical use in several countries. It has since become a widely prescribed medication for the treatment of anxiety and depression.
Related pages[edit]
-
Litracen
